Neurotech startup Paradromics has achieved a major milestone by successfully implanting its brain-computer interface in a human for the first time, paving the way for a clinical trial later this year to study the long-term safety and use of its technology.
The FDA has granted De Novo authorization to Clairity Breast, the first AI-powered platform that predicts a woman's risk of developing breast cancer over the next five years using only a standard mammogram, paving the way for more personalized and equitable breast cancer prevention and care.
Early AI investor Elad Gil is now betting big on using AI to transform traditional businesses through roll-ups, acquiring mature companies and using AI to radically increase their margins, then repeating the process to create tech-enabled giants in industries like legal services.
A new AI test can identify which men with high-risk prostate cancer will benefit most from the life-extending drug abiraterone, potentially saving lives and NHS costs by avoiding unnecessary treatment for those unlikely to benefit.
In a groundbreaking move, the FDA has announced an aggressive timeline to integrate AI across all centers by June 30, 2025, following a successful pilot that significantly reduced scientific review times from days to minutes, promising to accelerate the approval process for new therapies.
A panel of health leaders warns that by 2050, an alarming 1.3 billion people could have diabetes and over 5 billion may be insulin resistant, but AI technology tracking food composition and personalized health data offers hope for prevention and early intervention.
A creepy-looking AI robot nurse called Nurabot has been unveiled to tackle healthcare worker burnout by patrolling hospital halls, delivering medicine, tracking vitals, and potentially assisting with patient care tasks like lifting in the future.
AI's integration with precision medicine enables accurate cancer diagnoses, optimized treatments, and equitable solutions by leveraging pathomics, deep learning models like NAFNet for predicting outcomes, and developing population-specific AI models with diverse data sets.
A medical student and resident physician discuss their published manuscript on leveraging artificial intelligence (AI) to enhance equitable cancer care, highlighting AI's potential in improving diagnosis, treatment planning, increasing access through mobile tools, and addressing challenges like data bias and ethical implementation.
Foxconn is partnering with NVIDIA to develop smart hospital solutions, including collaborative nursing robots like Nurabot, AI models for patient monitoring, and digital twins of healthcare facilities, leveraging NVIDIA technologies from data centers to edge devices to transform medical centers into AI-powered smart hospitals.